Lv24
160 积分 2023-12-23 加入
Innovative molecules and delivery technologies enabling the future of GLP-1-based therapies
3天前
已完结
Time trends and regional variation in utilization of antidiabetic medicines in China, 2015-2022
11天前
已完结
Type 2 diabetes
21天前
已完结
Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment
22天前
已完结
Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity: A Phase 2 Randomized Clinical Trial
22天前
已完结
Muscle matters: the effects of medically induced weight loss on skeletal muscle
22天前
已完结
Sodium-glucose co-transporter 2 inhibitors and Sarcopenia: A controversy that must be solved
22天前
已完结
Dipeptidyl peptidase 4 inhibitors attenuates the decline of skeletal muscle mass in patients with type 2 diabetes
22天前
已完结
Is Weight Loss-Induced Muscle Mass Loss Clinically Relevant?
22天前
已完结
Sarcopenia in Elderly Diabetic Patients: Role of Dipeptidyl Peptidase 4 Inhibitors
22天前
已完结
皖公网安备34019202002308
